Full‑Length Mrna‑Seq For Genome Sequencing Content Creation

Featured Transcriptome & Genome Solutions

High-precision long-read sequencing and comprehensive genomic services engineered for breakthrough discoveries

Full-length mRNA sequencing -PacBio

Human Whole Exome Sequencing

Long Non-coding Sequencing-Illumina

Small RNA

The Paradigm Shift: Full-Length mRNA-Seq in Modern Genomics

Overcoming Assembly Artifacts to Characterize Complete Transcript Isoforms Without Fragmentation

Genome sequencing content creation has entered a transformative era driven by Third-Generation Long-Read Sequencing Technologies. Traditional Next-Generation Sequencing (NGS), while offering immense throughput, inherently suffers from read-length limitations (typically 150–300 bp). This constraint forces bioinformaticians to rely on algorithmic assembly to reconstruct transcripts, often leading to misaligned isoforms, lost alternative splicing variants, and incomplete 5' or 3' untranslated regions (UTRs).

Full-Length mRNA Sequencing (Full-Length mRNA-Seq), utilizing advanced platforms such as Pacific Biosciences (PacBio Iso-Seq) and Oxford Nanopore Technologies (ONT), bypasses cDNA fragmentation entirely. By sequencing intact full-length transcript molecules from the 5' cap to the 3' poly-A tail, full-length RNA sequencing provides an unambiguous map of transcriptome architecture. This breakthrough provides high-fidelity reference content essential for annotating complex genomes, identifying novel therapeutic targets, and understanding post-transcriptional regulatory networks.

🧬

Accurate Isoform Resolution

Directly read complete mRNA transcripts to distinguish subtle alternative splicing events, exon skipping, and alternative polyadenylation (APA) without computational guesswork.

🔬

De Novo Genome Annotation

Upgrade genomic database content for non-model organisms by providing precise gene boundaries, full coding sequences (CDS), and accurate untranslated region (UTR) maps.

⚡

Fusion Gene & Biomarker Discovery

Uncover complex chimeric transcripts, novel non-coding RNAs, and allele-specific gene expressions critical for oncology research and personalized clinical diagnostics.

Commercial Landscape & Industrial Market Trends

How Third-Generation Transcriptomics is Reshaping Biotech, Agriculture, and Pharmaceutical R&D

The global market for transcriptome sequencing is experiencing exponential growth, fueled by rising demand for RNA-based therapeutics, precision medicine, and advanced agricultural biotechnology. Industrial stakeholders and bio-repository content creators are rapidly shifting from short-read RNA-Seq toward long-read Full-Length mRNA-Seq due to several critical commercial drivers:

1. Acceleration of mRNA Vaccine & Therapeutic Design

In the biopharmaceutical sector, characterization of complete mRNA transcripts is essential for vector validation, therapeutic RNA stability analysis, and off-target expression profiling. Full-length sequencing allows pharmaceutical companies to inspect full mRNA drug constructs for structural integrity, poly-A tail uniformity, and fidelity prior to clinical trials.

Biomarker Technologies (BMKGene) supports drug developers by delivering ultra-deep long-read transcriptome profiling that guarantees full transcript assembly and rigorous quality metrics.

2. Crop Breeding & Agricultural Genomics Innovation

Modern agritech relies on accurate reference transcriptomes to engineer stress-resistant crops and improve livestock yields. Plant genomes are notoriously polyploid, repetitive, and complex. Full-length mRNA sequencing resolves homeolog-specific isoforms in complex plant genomes (e.g., wheat, cotton, sugarcane), unlocking metabolic pathways that were previously inaccessible via conventional short-read sequencing.

3. High-Quality Multi-Omics Data Monetization & Database Creation

Academic repositories, genomic databases, and commercial biobanks require comprehensive annotations to maximize the value of their sequenced genomes. Incorporating Full-Length mRNA-Seq data enriches genomic database content, making sequence repositories significantly more useful for functional studies, gene ontology mapping, and AI-driven protein folding predictions.

Deep-Dive Application Scenarios

Unlocking Biological Complexity Across Multi-Disciplinary Genomics Research

01

Single-Cell Full-Length Transcriptomics

Combining single-cell sequencing with long-read technologies allows researchers to map isoform diversity at single-cell resolution. This enables the discovery of cell-type-specific alternative splicing patterns in complex tissues like brain tissue and solid tumors.

02

Exosomal RNA Profiling

Extracellular vesicles carry intact and fragmented functional RNAs. Full-length exosomal RNA sequencing provides insights into intercellular communication, immune modulation, and non-invasive cancer biomarker identification.

03

Long Non-Coding RNA (lncRNA) Functional Annotation

lncRNAs often lack strong open reading frames and possess low expression levels. Full-length sequencing captures complete lncRNA structures without assembly artifacts, clarifying their regulatory roles in epigenetics.

Biomarker Technologies (BMKGene) Capabilities

Over 16 Years of Continuous Innovation in High-Throughput Sequencing and Bioinformatic Cloud Solutions

Biomarker Technologies (BMKGene), founded in 2009, is a leading global provider of multi-omics services. Backed by more than 60 national invention patents and over 200 software copyrights, BMKGene delivers comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.

Leading Multi-level High-throughput Sequencing Platforms

Leading Multi-level Platforms

PacBio: Sequel II, Sequel, RSII
Nanopore: PromethION P48, GridION X5, MinION
10X Genomics: ChromiumX, Controller
Illumina: NovaSeq
BGI: DNBSEQ-G400, DNBSEQ-T7
Mass Spectrometry: Waters XEVO G2-XS QTOF, QTRAP 6500+

Professional Automatic Molecular Laboratory

State-of-the-Art Molecular Lab

Spanning over 20,000 square feet of automated lab space equipped with advanced biomolecular instruments. Standardized operating procedures (SOPs) guide sample extraction, library construction, clean rooms, and sequencing operations under ISO-certified quality controls.

BMKCloud Computing Infrastructure

Self-developed high-performance BMKCloud bioinformatic analysis platform. Features CPUs with 41,104 memory, 3 PB total storage capacity, and 4,260 computing cores delivering peak computing power over 121,708.8 Gflop/s for seamless big-data processing.

Automated High-Throughput Execution: Brilliant Lab 1000

Joint Innovation by Biomarker Technologies and PerkinElmer for NGS Library Construction

Brilliant Lab 1000 (BL1000) Automation Platform

Biomarker Technologies (BMKGene) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to high-throughput NGS library construction services.

By automating liquid handling, library prep, and quality verification, BMKGene dramatically enhances sequencing output across product categories, guaranteeing high delivery quality, minimized batch-to-batch variation, and rapid turnaround times for global clients.